Metabolites Emerge as Signaling Hubs Driving Diabetic Kidney Disease
A new review reframes diabetic kidney disease as a network-level disease driven by metabolites acting as signaling mediators, biomarkers and ...
A new review reframes diabetic kidney disease as a network-level disease driven by metabolites acting as signaling mediators, biomarkers and ...
A narrative review argues that sepsis is a biologically heterogeneous syndrome whose reproducible subphenotypes may eventually guide targeted treatment, though ...
A new narrative review in BMC Rheumatology summarises current best practice for managing systemic sclerosis, highlighting cellular therapies, multi-omics and ...
A new framework recalibrates published polygenic risk scores to local biobank data, improving risk prediction for coronary artery disease, breast ...
A narrative review argues that photobiomodulation's strongest evidence lies in oral mucositis prevention, while inconsistent dosimetry and reporting standards hold ...
More than 30 experts outline how patients' germline genomes could improve infectious disease care, from detecting rare immune disorders early ...
A perspective in Critical Care argues that pneumonia-associated sepsis should be understood as a multidimensional syndrome driven by loss of ...
A new perspective argues that pharmacogenomic testing could improve emergency department prescribing, but no randomized controlled trials have yet tested ...
A computational study built a gut microbiota–metabolite–host gene score that stratified rheumatoid arthritis patients into two molecular subtypes and predicted ...
A new narrative review maps the genetic architecture, regulatory landscape and emerging precision therapies for Charcot-Marie-Tooth disease type 1A.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine